99mTc-labeled Affibody imaging agent for HER2
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for 99mTc-labeled Affibody imaging agent for HER2, covering 2018-06-06 to 2018-06-06. Get the full timeline:
Most recent: Clinical Trial Update: 99mTc Labelled Affibody SPECT/CT Imaging for Breast Cancer HER2 Characterization [EARLY_Phase 1]